Our webinar series offers firsthand insights from experts, scientists, and clinicians about C3 Glomerulopathy (C3G) and Fabry Disease such as epidemiology, diagnosis, treatment, management, and coping strategies. You will hear about all the relevant aspects, including Eleva’s initiatives to develop new treatment options for these rare diseases with high unmet medical needs. Join the series for regular updates on Eleva’s clinical development efforts.